1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA APBB1 CTRPv2 pan-cancer AAC 0.12 0.001
mRNA DSTN CTRPv2 pan-cancer AAC -0.12 0.001
mRNA TNFRSF1A CTRPv2 pan-cancer AAC -0.11 0.001
mRNA IL3RA CTRPv2 pan-cancer AAC 0.11 0.001
mRNA CTD-2369P2.12 CTRPv2 pan-cancer AAC 0.12 0.001
mRNA CBR1 CTRPv2 pan-cancer AAC -0.11 0.001
mRNA RASGRP2 CTRPv2 pan-cancer AAC 0.13 0.001
mRNA L3MBTL2 CTRPv2 pan-cancer AAC 0.11 0.001
mRNA ARVCF CTRPv2 pan-cancer AAC 0.11 0.001
mRNA LMCD1 CTRPv2 pan-cancer AAC -0.11 0.001
Download CSV